Hermetica Superfood Encyclopedia
The Short Answer
Ficus racemosa contains stigmasterol, gallic acid, pentadecanoic acid, and epicatechin as primary bioactives that exert antibacterial, antifungal, and antioxidant activity through microbial enzyme inhibition and free-radical scavenging. In preclinical GC-MS and docking studies, stigmasterol recorded the highest binding affinity against bacterial and fungal targets (outperforming chloramphenicol at -3.533 kcal/mol and fluconazole at -5.391 kcal/mol), while HPLC-quantified gallic acid (50.11 mg/100 g dry fruit extract) contributed an RC50 reducing-power value of 40.443 μg/mL.
CategoryHerb
GroupSoutheast Asian
Evidence LevelPreliminary
Primary KeywordFicus racemosa benefits
Cluster Fig — botanical close-up
Health Benefits
**Antioxidant Protection**: Gallic acid (50
11 mg/100 g), catechin hydrate (25.34 mg/100 g), and epicatechin (22.14 mg/100 g) in the fruit methanol extract scavenge superoxide, hydroxyl, and hydrogen peroxide radicals, yielding a total phenolic content of 26.2 mg GAE/g and an RC50 of 40.443 μg/mL, moderately below the 27.589 μg/mL of ascorbic acid.
**Antibacterial Activity**
Stigmasterol and phenolic constituents inhibit bacterial growth with MIC values of 50–150 μL against organisms including Escherichia coli; stigmasterol's molecular docking score exceeds chloramphenicol, suggesting binding to critical active-site residues in bacterial enzyme targets.
**Antifungal Effects**
Stigmasterol from fruit extracts demonstrates docking affinity against Candida albicans targets superior to fluconazole (-5.391 kcal/mol reference), supported by ADME and molecular dynamics simulations confirming drug-like stability and membrane penetration potential.
**Anti-inflammatory and Wound Healing**
Bark and leaf preparations containing β-sitosterol, tannins, and flavonoids are traditionally applied to wounds, skin inflammations, and ulcers; β-sitosterol inhibits pro-inflammatory arachidonic acid pathways and modulates NF-κB signalling in preclinical models.
**Hypoglycaemic Potential**
β-Sitosterol and leaf-derived polyphenolic fractions have demonstrated blood-glucose-lowering effects in animal models of diabetes, with compound preparations containing F. racemosa leaves increasing circulating insulin levels, implicating improved pancreatic β-cell function or peripheral insulin sensitisation.
**Haemorrhoidal Relief (Traditional Piles Remedy)**
In Malaysian ethnomedicine, the plant is specifically used for haemorrhoids (piles), with bergenin identified as a relevant bioactive; astringent tannins and anti-inflammatory sterols are thought to reduce venous engorgement, mucosal irritation, and bleeding.
**Digestive and Antidiarrhoeal Properties**
Tannins, saponins, and gallic acid in bark and fruit decoctions exert astringent and antimicrobial actions on the gastrointestinal mucosa, supporting traditional use for diarrhoea, dysentery, and intestinal infections across Ayurvedic and Southeast Asian folk systems.
Origin & History
Natural habitat
Ficus racemosa L. is native to South and Southeast Asia, including India, Malaysia, Indonesia, Sri Lanka, and extending into tropical Australia, typically growing along riverbanks, moist forests, and disturbed lowland habitats. It thrives in tropical and subtropical climates with high humidity and well-drained alluvial soils, often found at elevations below 1,200 metres. The tree is cultivated semi-formally in village homegardens and sacred groves across the Indian subcontinent and the Malay Peninsula, where its fruits, bark, leaves, and roots are harvested for both food and traditional medicine.
“Ficus racemosa has been documented in classical Ayurvedic texts, including the Charaka Samhita and Sushruta Samhita, where it is referred to as 'Udumbara' and prescribed for haemorrhoids, diabetes, leucorrhoea, menorrhagia, and urinary disorders, with the fruit, bark, and root each assigned distinct therapeutic roles. In Malaysian traditional medicine, the plant is prominently used for piles (haemorrhoids), with leaves and fruits prepared as decoctions or applied topically, and bergenin has been identified as a pharmacologically relevant constituent linking the plant's folk use to measurable bioactivity. Across Indonesian, Sri Lankan, and Thai folk systems, the tree holds cultural significance as a sacred or semi-sacred fig species—related symbolically to Ficus religiosa—and is planted near temples and community spaces. The tree's vernacular names reflect its geographic spread: 'gular' or 'goolar' in Hindi, 'atti' in Tamil, 'ara' in Malay, and 'cluster fig' in English, each associated with regional preparation traditions spanning fresh fruit consumption to dried bark powders mixed with honey.”Traditional Medicine
Scientific Research
The evidence base for Ficus racemosa is currently limited to in vitro biochemical assays, GC-MS and HPLC phytochemical profiling, computational molecular docking studies (ADME, DFT, and molecular dynamics), and a small number of animal model experiments; no published randomised controlled trials in human participants have been identified in the peer-reviewed literature as of the time of writing. Preclinical antioxidant data report a total antioxidant optical density of 0.934 ± 0.06 (p < 0.05) in a dose-dependent manner, and antibacterial MIC values of 50–150 μL against E. coli, but standardised dosing units and comparator arms are inconsistently reported across studies. Animal model data suggest hypoglycaemic effects and elevated plasma insulin in compound herbal preparations containing F. racemosa leaves, though the specific contribution of F. racemosa versus co-administered ingredients cannot be isolated from these studies. The computational evidence is methodologically robust for a preliminary stage, with DFT-optimised geometries and molecular dynamics confirming stigmasterol's conformational stability in target binding pockets, but this does not substitute for pharmacokinetic or clinical validation.
Preparation & Dosage
Traditional preparation
**Fruit Decoction (Traditional)**
10–15 g crude material per 200 mL) and consumed orally; used in Ayurvedic practice for digestive complaints and haemorrhoids, typically 1–2 times daily
Dried or fresh fruits are boiled in water (approximately .
**Bark Decoction (Traditional)**
5–10 g) is decocted in water and used for diarrhoea, dysentery, and wound washing; no standardised dose has been established in controlled studies
Bark (.
**Methanol/Ethanol Extract (Research Grade)**
Laboratory extracts are prepared by maceration of dried plant material in 70–100% methanol or ethanol; these are not commercially standardised preparations and are not suitable for direct supplemental use without further processing.
**Leaf Paste or Poultice (Topical)**
Fresh leaves are ground and applied topically to wounds, skin infections, and inflamed tissues in Southeast Asian folk traditions; frequency and quantity are empirically determined.
**Standardisation Status**
No internationally recognised standardised extract specifying minimum percentages of gallic acid, stigmasterol, or bergenin is currently available in the commercial supplement market; all dose ranges remain empirical and preclinical.
**Timing Notes**
Traditional oral preparations are generally taken on an empty stomach or with meals depending on the indication; no pharmacokinetic data exist to guide optimal timing in humans.
Nutritional Profile
Ficus racemosa fruits contain a moderate profile of phenolic acids, with gallic acid at 50.11 mg/100 g, catechin hydrate at 25.34 mg/100 g, epicatechin at 22.14 mg/100 g, vanillic acid at 16.38 mg/100 g, and coumaric acid at 12.06 mg/100 g in the dry methanol extract. Fatty acid constituents include hexadecanoic acid (palmitic acid, ~10.031% of GC-MS volatile fraction), pentadecanoic acid (~14.256%), and a methyl ester of (Z)-9,12-octadecadienoic acid (linoleic acid derivative), contributing to the plant's lipid profile. Phytosterols including stigmasterol and β-sitosterol are present at pharmacologically relevant but unquantified absolute concentrations in available literature. Total phenolic content is 26.2 mg GAE/g in fruit extract and 20.2 mg GAE/g in leaf extract; alkaloids, tannins, saponins, and glauanol are detected qualitatively. Bioavailability of polyphenols is subject to first-pass metabolism and gut microbiota biotransformation, and no human pharmacokinetic data exist to define actual systemic exposure.
How It Works
Mechanism of Action
Stigmasterol (trans-stigmasta-5,22-dien-3β-ol), the lead compound identified by molecular docking, binds critical amino acid residues within bacterial and fungal enzymatic targets with solvation energies approximating 46.406 kcal/mol, satisfying Lipinski's rule of five and predicting favourable oral bioavailability and membrane permeability. Gallic acid and epicatechin donate hydrogen atoms to neutralise reactive oxygen species including superoxide anion, hydroxyl radical, and hydrogen peroxide, thereby attenuating lipid peroxidation and oxidative cellular damage at sub-millimolar concentrations. β-Sitosterol interferes with cholesterol absorption at the intestinal brush border and suppresses NF-κB-mediated cytokine transcription (including TNF-α and IL-6), contributing to the anti-inflammatory and hypoglycaemic profiles observed in vivo. Bergenin, a C-glucoside of 4-O-methylgallic acid, may inhibit phosphodiesterase and modulate cAMP-dependent signalling, offering a mechanistic rationale for its documented anti-inflammatory and venotonic effects relevant to haemorrhoidal conditions.
Clinical Evidence
To date, no human clinical trials with defined sample sizes, randomisation procedures, or formally measured primary endpoints have been published for Ficus racemosa as an isolated intervention. The existing preclinical dataset supports biologically plausible antioxidant, antimicrobial, and glycaemic-modulating activities, but effect sizes extrapolated to humans remain speculative. Animal studies involving compound preparations suggest insulin-secretagogue or insulin-sensitising effects, yet confounding from multi-herb formulations prevents attribution of outcomes specifically to F. racemosa. Confidence in clinical application is therefore low, and practitioners should regard current findings as hypothesis-generating rather than practice-defining until appropriately powered human trials are conducted.
Safety & Interactions
Ficus racemosa is broadly regarded as safe within traditional use contexts at food-relevant and low-to-moderate medicinal doses, with no formally documented adverse event reports in the peer-reviewed clinical literature; however, in vitro cytotoxic activity has been observed in concentrated extracts, indicating potential cell toxicity at high or supra-therapeutic doses that warrants caution. No specific drug-drug interactions have been characterised in controlled studies, but the plant's β-sitosterol content could theoretically potentiate lipid-lowering agents (statins, ezetimibe) and its hypoglycaemic activity may additive with antidiabetic medications (metformin, sulfonylureas, insulin), increasing hypoglycaemia risk. Contraindications have not been formally established; however, pregnant and lactating women should avoid concentrated extracts in the absence of safety data, particularly given the presence of bioactive alkaloids and saponins with uncertain gestational toxicity profiles. Maximum safe doses in humans have not been defined, and all available safety assessments derive from traditional-use precedent and limited in vitro toxicology rather than clinical dose-escalation trials.
Synergy Stack
Hermetica Formulation Heuristic
Also Known As
Ficus racemosa L.Cluster FigUdumbaraGularGoolarAttiAraCountry Fig
Frequently Asked Questions
What is Ficus racemosa traditionally used for in Malaysian medicine?
In Malaysian traditional medicine, Ficus racemosa is primarily used to treat haemorrhoids (piles), with leaves and fruit preparations applied both orally and topically to reduce venous inflammation and bleeding. Bergenin, a C-glucoside derivative of gallic acid identified in the plant, is considered a key bioactive compound relevant to this use, likely contributing through anti-inflammatory and venotonic mechanisms. No clinical trials have confirmed efficacy in humans, but ethnobotanical documentation across Malaysia is well-established.
What are the main bioactive compounds in Ficus racemosa fruit?
HPLC analysis of the methanol fruit extract identifies gallic acid (50.11 mg/100 g), catechin hydrate (25.34 mg/100 g), epicatechin (22.14 mg/100 g), vanillic acid (16.38 mg/100 g), and coumaric acid (12.06 mg/100 g) as the dominant phenolic compounds. GC-MS analysis additionally identifies stigmasterol as the lead phytosterol with the highest molecular docking scores against bacterial and fungal targets, alongside fatty acids including pentadecanoic acid (~14.256%) and hexadecanoic acid (~10.031%). β-Sitosterol, glauanol, alkaloids, tannins, and saponins are also present across different plant parts.
Does Ficus racemosa have antibacterial or antifungal properties?
Preclinical studies demonstrate that Ficus racemosa extracts inhibit bacterial growth with MIC values of 50–150 μL against organisms including Escherichia coli. Molecular docking studies show stigmasterol binding bacterial and fungal enzyme targets with affinity exceeding that of reference antibiotics chloramphenicol (-3.533 kcal/mol) and antifungal fluconazole (-5.391 kcal/mol), with ADME and molecular dynamics analyses supporting its drug-likeness. These findings are currently limited to computational and in vitro contexts, and clinical antimicrobial efficacy in humans has not been established.
Is Ficus racemosa safe to consume, and are there any known side effects?
Ficus racemosa is generally regarded as safe based on its long history of food and medicinal use across South and Southeast Asia, and no specific adverse events have been formally documented in peer-reviewed clinical literature. However, in vitro studies have demonstrated cytotoxic activity at concentrated extract doses, indicating that high-dose supplementation could carry cell-toxicity risks not yet characterised in human studies. Individuals taking antidiabetic or lipid-lowering medications should use caution due to potential additive effects with β-sitosterol and hypoglycaemic plant constituents, and pregnant or breastfeeding women should avoid concentrated preparations until safety data are available.
What is the evidence for Ficus racemosa's ability to lower blood sugar?
Preclinical animal model data indicate that compound herbal preparations containing Ficus racemosa leaves can lower blood glucose and increase circulating insulin, implicating either improved pancreatic β-cell secretion or enhanced peripheral insulin sensitivity. β-Sitosterol, present in the plant, has a documented mechanism of interfering with NF-κB-mediated inflammatory signalling and modulating glucose transporter expression in rodent studies. Critically, no isolated randomised controlled trials in human participants have evaluated F. racemosa specifically for diabetes management, and current evidence remains insufficient to support clinical recommendations.
How does Ficus racemosa compare to other antioxidant herbs in terms of radical scavenging ability?
Ficus racemosa fruit extract demonstrates moderate antioxidant potency with an RC50 of 40.443 μg/mL, which is slightly less potent than ascorbic acid (27.589 μg/mL) but competitive with many botanical antioxidants. The high concentration of gallic acid (50.11 mg/100 g), catechin hydrate (25.34 mg/100 g), and epicatechin (22.14 mg/100 g) in the methanol extract effectively neutralizes superoxide, hydroxyl, and hydrogen peroxide radicals. Its total phenolic content of 26.2 mg GAE/g positions it as a solid contributor to antioxidant protection when used as a dietary supplement ingredient.
Are there specific populations who should consider Ficus racemosa supplementation for antioxidant support?
Individuals with elevated oxidative stress—such as those with metabolic disorders, chronic inflammation, or poor dietary antioxidant intake—may benefit from Ficus racemosa's polyphenol profile. People seeking plant-based alternatives to synthetic antioxidants or those already managing blood sugar may find dual benefit in this herb, given its traditional use and emerging research support. However, those taking anticoagulant medications or with bleeding disorders should consult a healthcare provider before supplementation due to potential interactions with phenolic compounds.
What extraction method yields the highest antioxidant content from Ficus racemosa fruit?
Methanol extraction has been documented to produce the most active antioxidant profile, delivering gallic acid, catechin hydrate, and epicatechin in concentrated amounts with an RC50 of 40.443 μg/mL. While methanol is used in research and commercial processing, the bioavailability of these polyphenols when consumed as a supplement may vary depending on whether the final product uses aqueous, hydroalcoholic, or standardized extract formats. Standardized extracts targeting total phenolic content (26.2 mg GAE/g or higher) are likely to provide more consistent antioxidant efficacy than whole fruit powders.
Explore the Full Encyclopedia
7,400+ ingredients researched, verified, and formulated for optimal synergy.
Browse IngredientsThese statements have not been evaluated by the Food and Drug Administration. This content is for informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease.
hermetica-encyclopedia-canary-zzqv9k4w cluster-fig-ficus-racemosa-l curated by Hermetica Superfoods at ingredients.hermeticasuperfoods.com and licensed CC BY-NC-SA 4.0 (non-commercial share-alike, attribution required)
